ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Topic: Third Rock Ventures

No shying away from early-stage deals here. Third Rock Ventures raises $516M for startups

No shying away from early-stage deals here. Third Rock Ventures raises $516M for startups

March 25, 2013 10:17 am by | 0 Comments

While many healthcare venture capital firms continue to ease away from early-stage deals, Third Rock Ventures has just restocked with $516 million to continue backing them.With its third fund, the ... Read more
Drug that targets biological factors associated with obesity progresses to phase 2 trials

Drug that targets biological factors associated with obesity progresses to phase 2 trials

September 18, 2012 10:35 am by | 0 Comments

There’s no shortage of innovative approaches to helping people lose weight today, whether it’s filling space in the stomach to create an artificial sense of fullness, using neuromodulation to keep ... Read more
Venture firm launches rare blood disorder therapeutics developer with $41M

Venture firm launches rare blood disorder therapeutics developer with $41M

June 14, 2012 3:09 pm by | 0 Comments

Venture capital firm Third Rock Ventures has launched a drug development startup to treat genetic blood disorders, with sickle-cell anemia as its lead program target, providing $40.7 million in series ... Read more
‘Painless’ blood draw device using microneedles could be available in 2013

‘Painless’ blood draw device using microneedles could be available in 2013

April 19, 2012 5:16 pm by | 1 Comments

How much more likely would a diabetic be to check his blood sugar regularly, or a nervous patient to fulfill her doctor’s request for blood work, if there were no ... Read more
What will Novartis’ multiple sclerosis pill cost? (Morning Read)

What will Novartis’ multiple sclerosis pill cost? (Morning Read)

September 23, 2010 8:43 am by | 0 Comments

Swiss drugmaker Novartis just got Food and Drug Administration approval to sell the first pill that can slow the progression of multiple sclerosis. Gilenya will go head-to-head with injectable medicines, ... Read more
Third Rock Ventures raises $426M, opens West Coast office

Third Rock Ventures raises $426M, opens West Coast office

September 14, 2010 7:05 pm by | 0 Comments

Boston investment firm Third Rock Ventures LLC has raised $426 million for its second (oversubscribed) fund and is opening a San Francisco office to continue its practice of "launching ... Read more